SOX11 and mantle cell lymphoma: The second is non-nodal leukemic MCL (10–20% of cases) with mutated IGHV, SOX11 negativity, lymphocytosis, splenomegaly, and typically indolent biological behavior due to low numbers of genetic lesions and epigenetic modifications.